Coalition Letter: Clarification of Eligibility for Small Businesses with Equity Investors under the SBA’s 7(a) Loan Program within the CARES Act

Global & Trade

Global Medical Technology Alliance: Open letter to the G-20 Heads of State and Government: Need to collaborate to open global trade in response to COVID-19

Regulatory Affairs

AdvaMed Letter to FDA: Letter to Owen Faris RE Clinical Trials Flex Proposals

“Dear Governor” Letter from 8 national health care products trade groups

Legal / Value-Based Collaborations

May 8, 2019 AdvaMed Letter Refining Value-Based Safe Harbor Proposals

Legal / Value-Based Collaborations

AdvaMed Statement on Health Care Innovation Caucus RFI Regarding Value-Based Arrangements

Diagnostics / Regulatory Affairs

AdvaMedDx Letter to Sen. Alexander and Murray and Rep. Walden and Pallone

Legal / Value-Based Collaborations

AdvaMed 2018 AKS Safe Harbor Proposals For Value-Based Arrangements

Legal / Physicians Payment Sunshine Act / Value-Based Collaborations

AdvaMed 2017 AKS Safe Harbor Proposals For Value-Based Arrangements

Regulatory Affairs

FDA Response Letter to AdvaMed’s UDI Cross Reference Proposal

FDA sent this letter in response to issues AdvaMed raised to the FDA regarding implementation of the UDI rule.